Respuestas de inmunidad celular en la tuberculosis pulmonar.
Human pulmonary tuberculosis (TB) is a worldwide public health problem, which is caused by Mycobacterium tuberc-ulosis. It is a fact that one third of the world ' s population is infected with this mycobacteria, however , only a minority of people infected by M. tuberc-ulosis may develop a clinical...
Saved in:
| Udgivet: |
2005
|
|---|---|
| Fag: | |
| Online adgang: | http://hdl.handle.net/10872/17525 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
| _version_ | 1870622067059064832 |
|---|---|
| bitstream.checksum.fl_str_mv | b8d458abb80725c129a1e8b6f007ec1f 7c020282d630887ba819753d2e4a4c58 |
| bitstream.checksumAlgorithm.fl_str_mv | MD5 MD5 |
| bitstream.url.fl_str_mv | https://saber.ucv.ve/jspui/bitstream/10872/17525/1/Investigacion.Clinica.2005.pdf https://saber.ucv.ve/jspui/bitstream/10872/17525/2/license.txt |
| dc.contributor.author.none.fl_str_mv | Araujo, Zaida Vieyra- Reyes, Patricia Rivas-Santiago, Bruno |
| dc.creator.fl_str_mv | Araujo, Zaida Vieyra- Reyes, Patricia Rivas-Santiago, Bruno |
| dc.date.accessioned.none.fl_str_mv | 2018-01-15T15:32:24Z |
| dc.date.available.none.fl_str_mv | 2018-01-15T15:32:24Z |
| dc.date.issued.none.fl_str_mv | 2005 |
| dc.identifier.citation.en_US.fl_str_mv | Araujo, Z. Et All. Respuestas de inmunidad celular en la tuberculosis pulmonar. Investigacion Clinica 46 (4) 391-412 |
| dc.identifier.issn.none.fl_str_mv | 0535-5133 |
| dc.identifier.uri.none.fl_str_mv | http://hdl.handle.net/10872/17525 |
| dc.language.iso.en_US.fl_str_mv | es |
| dc.publisher.en_US.fl_str_mv | Investigacion Clinica |
| dc.subject.en_US.fl_str_mv | Tuberculosis mycobacterium tuberculosis Alveolar macrophages monocyte macrophages |
| dc.title.en_US.fl_str_mv | Respuestas de inmunidad celular en la tuberculosis pulmonar. |
| dc.type.en_US.fl_str_mv | Article |
| description | Human pulmonary tuberculosis (TB) is a worldwide public health problem, which is caused by Mycobacterium tuberc-ulosis. It is a fact that one third of the world ' s population is infected with this mycobacteria, however , only a minority of people infected by M. tuberc-ulosis may develop a clinical dis- ease. In general, about 90% have their bacilli under control in a latent state throughout their lives by means of their immune responses. About 5% will de- velop primary progressive TB and th<} remaining 5% will develop the disease in the later stages of their lives, which is known as reactivation or post-primary TB. In resistant individua1s, control of the infection mainly requires develop- ment of a Thl cell immunity response. This type of response involves participa- tion of a1veolar macrophages and T CD4 + , CD8 + and T yt5 Iymphocytes, and production of cytokines such as IL-2, IFN-y, IL-12, IL-18 and TNF-a, as well as chemokines such as MNTES, MCP-l, MIP-la and IL-8 which playan important role in the migration of different cell subpopulations to the infection site for the formation of granulome. In addition, the role of "natural killer" (NK) cells, a1ong with epitelial cells, is essentia1 as part of the innate immune response. |
| id | SABERUCV_ee0e295dff701d0e2a055edee91c69dc |
| identifier_str_mv | Araujo, Z. Et All. Respuestas de inmunidad celular en la tuberculosis pulmonar. Investigacion Clinica 46 (4) 391-412 0535-5133 |
| language_invalid_str_mv | es |
| network_acronym_str | SABERUCV |
| network_name_str | Repositorio Institucional de la Universidad Central de Venezuela |
| oai_identifier_str | oai:saber.ucv.ve:10872/17525 |
| publishDate | 2005 |
| publishDateSort | 2005 |
| repository.mail.fl_str_mv | sfwrussians@gmail.com |
| repository.name.fl_str_mv | Saber UCV |
| repository_id_str | |
| spelling | Araujo, ZaidaVieyra- Reyes, PatriciaRivas-Santiago, Bruno2018-01-15T15:32:24Z2018-01-15T15:32:24Z2005Araujo, Z. Et All. Respuestas de inmunidad celular en la tuberculosis pulmonar. Investigacion Clinica 46 (4) 391-4120535-5133http://hdl.handle.net/10872/17525Human pulmonary tuberculosis (TB) is a worldwide public health problem, which is caused by Mycobacterium tuberc-ulosis. It is a fact that one third of the world ' s population is infected with this mycobacteria, however , only a minority of people infected by M. tuberc-ulosis may develop a clinical dis- ease. In general, about 90% have their bacilli under control in a latent state throughout their lives by means of their immune responses. About 5% will de- velop primary progressive TB and th<} remaining 5% will develop the disease in the later stages of their lives, which is known as reactivation or post-primary TB. In resistant individua1s, control of the infection mainly requires develop- ment of a Thl cell immunity response. This type of response involves participa- tion of a1veolar macrophages and T CD4 + , CD8 + and T yt5 Iymphocytes, and production of cytokines such as IL-2, IFN-y, IL-12, IL-18 and TNF-a, as well as chemokines such as MNTES, MCP-l, MIP-la and IL-8 which playan important role in the migration of different cell subpopulations to the infection site for the formation of granulome. In addition, the role of "natural killer" (NK) cells, a1ong with epitelial cells, is essentia1 as part of the innate immune response.esInvestigacion ClinicaTuberculosismycobacterium tuberculosisAlveolar macrophagesmonocytemacrophagesRespuestas de inmunidad celular en la tuberculosis pulmonar.ArticleORIGINALInvestigacion.Clinica.2005.pdfInvestigacion.Clinica.2005.pdfapplication/pdf2396612https://saber.ucv.ve/jspui/bitstream/10872/17525/1/Investigacion.Clinica.2005.pdfb8d458abb80725c129a1e8b6f007ec1fMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81509https://saber.ucv.ve/jspui/bitstream/10872/17525/2/license.txt7c020282d630887ba819753d2e4a4c58MD5210872/17525oai:saber.ucv.ve:10872/175252018-01-15 15:32:24.96Saber UCVsfwrussians@gmail.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 |
| spellingShingle | Respuestas de inmunidad celular en la tuberculosis pulmonar. Tuberculosis mycobacterium tuberculosis Alveolar macrophages monocyte macrophages |
| title | Respuestas de inmunidad celular en la tuberculosis pulmonar. |
| title_full | Respuestas de inmunidad celular en la tuberculosis pulmonar. |
| title_fullStr | Respuestas de inmunidad celular en la tuberculosis pulmonar. |
| title_full_unstemmed | Respuestas de inmunidad celular en la tuberculosis pulmonar. |
| title_short | Respuestas de inmunidad celular en la tuberculosis pulmonar. |
| title_sort | Respuestas de inmunidad celular en la tuberculosis pulmonar. |
| topic | Tuberculosis mycobacterium tuberculosis Alveolar macrophages monocyte macrophages |
| url | http://hdl.handle.net/10872/17525 |